Beijing Shenzhou Cell Biotechnology Group Co., Ltd. files for listing on the Hong Kong Stock Exchange

Mars Finance News: On May 22, Beijing Shenzhou Cell Biotechnology Group Co., Ltd. submitted an application for listing to the Hong Kong Stock Exchange, with CITIC Securities as the exclusive sponsor. (Ke Gu Bao Report)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 9
  • 1
  • Share
Comment
Add a comment
Add a comment
OutsiderOfZhiyuandao
· 9h ago
Traditional pharmaceutical companies cluster in Hong Kong stocks; the valuation system for innovative drugs needs to be rebuilt
View OriginalReply0
RugproofRookie
· 11h ago
CITIC Securities has recently had quite a few biotech and pharmaceutical projects.
View OriginalReply0
DaoDoorKeeper
· 11h ago
Does the product pipeline of Shen Zhou Cell look promising?
View OriginalReply0
LighthouseInTheMist
· 11h ago
Biotechnology Group, just hearing the name sounds like money burning.
View OriginalReply0
LookingAtTheCandlestickChart
· 11h ago
The Kegu Bao broadcast speed is good; it was out right after submission.
View OriginalReply0
TreatMemesAsBeliefs
· 11h ago
Switching from the STAR Market to Hong Kong stocks, with less valuation pressure
View OriginalReply0
GateUser-23bf1070
· 11h ago
In the cell therapy sector, Hong Kong stocks are indeed more friendly than A-shares.
View OriginalReply0
OtcMoonwalker
· 11h ago
The listing application has been submitted, and the next step is the hearing.
View OriginalReply0
GateUser-e1cfc287
· 11h ago
The Hong Kong stock biological medicine sector is about to get lively again
View OriginalReply0
View More
  • Pinned